Armata Pharmaceuticals, Inc.
ARMP
$9.00
$0.182.04%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -173.80M | -46.90M | -25.71M | -426.00K | -18.92M |
| Total Depreciation and Amortization | 1.53M | 1.49M | 1.44M | 1.39M | 1.33M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 147.92M | 18.58M | -4.37M | -33.90M | -17.86M |
| Change in Net Operating Assets | -1.41M | -190.00K | -2.94M | -1.60M | -2.10M |
| Cash from Operations | -25.76M | -27.02M | -31.58M | -34.55M | -37.55M |
| Capital Expenditure | -542.00K | -413.00K | -511.00K | -1.73M | -1.88M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -542.00K | -413.00K | -511.00K | -1.73M | -1.88M |
| Total Debt Issued | 25.00M | 25.00M | 10.00M | 10.00M | 34.89M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 658.00K | 0.00 | 0.00 | 88.00K | 130.00K |
| Repurchase of Common Stock | -46.00K | -46.00K | -75.00K | -75.00K | -61.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.61M | 24.95M | 9.93M | 10.01M | 34.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -693.00K | -2.48M | -22.17M | -26.26M | -4.47M |